
Precipio PRPO
€ 23.41
0.11%
Precipio EV/EBITDA | PRPO
EV/EBITDA Jährlich Precipio
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 988 | -12.8 | -1.7 | -0.213 | -1.8 | -5.62 | -1.35 | -1.1 | -1.53 | -3.15 | -1.73 | -2.27 | - | - | - | -6.41 | 5.4 | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 988 | -12.8 | 68.1 |
EV/EBITDA anderer Aktien in der Diagnostik & Forschung
| Name | EV/EBITDA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Neuronetics
STIM
|
-6.02 | $ 2.93 | 1.74 % | $ 193 M | ||
|
Thermo Fisher Scientific
TMO
|
21.2 | $ 603.02 | 0.02 % | $ 227 B | ||
|
Twist Bioscience Corporation
TWST
|
-13.9 | $ 128.06 | 2.68 % | $ 7.66 B | ||
|
Senseonics Holdings
SENS
|
-5.62 | $ 9.33 | 5.97 % | $ 389 M | ||
|
Sotera Health Company
SHC
|
74.5 | $ 18.59 | 0.05 % | $ 5.28 B | ||
|
VolitionRx Limited
VNRX
|
-3.21 | $ 0.33 | 2.52 % | $ 41.5 M | ||
|
Waters Corporation
WAT
|
60.2 | $ 402.91 | 0.33 % | $ 24 B | ||
|
Exagen
XGN
|
-6.55 | $ 7.3 | 0.53 % | $ 157 M | ||
|
Akumin
AKU
|
23.4 | - | -17.87 % | $ 25.9 M | ||
|
Trinity Biotech plc
TRIB
|
-15.5 | $ 9.06 | 0.64 % | $ 3.25 B | ||
|
Accelerate Diagnostics
AXDX
|
-2.05 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
-0.496 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
-1.86 | - | 0.22 % | $ 16.8 M | ||
|
Heska Corporation
HSKA
|
-134 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.156 | - | -20.0 % | $ 1.06 M | ||
|
Psychemedics Corporation
PMD
|
-2.23 | - | -1.84 % | $ 15.3 M | ||
|
Quotient Limited
QTNT
|
-2.83 | - | -11.32 % | $ 1.1 M | ||
|
Quest Diagnostics Incorporated
DGX
|
10.8 | $ 235.5 | 0.06 % | $ 26.1 B | ||
|
Syneos Health
SYNH
|
7.06 | - | - | $ 4.46 B | ||
|
T2 Biosystems
TTOO
|
-1.13 | - | -39.35 % | $ 313 K | ||
|
Meridian Bioscience
VIVO
|
18.4 | - | - | $ 1.49 B | ||
|
Motus GI Holdings
MOTS
|
-0.0496 | - | -34.28 % | $ 263 K | ||
|
Brainsway Ltd.
BWAY
|
166 | $ 14.16 | 0.07 % | $ 481 M | ||
|
Renalytix AI plc
RNLX
|
-1.16 | - | 5.66 % | $ 22.7 M | ||
|
DermTech
DMTK
|
-0.68 | - | -11.32 % | $ 2.94 M | ||
|
Quidel Corporation
QDEL
|
9.16 | $ 13.38 | 0.29 % | $ 564 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-73.4 | - | - | $ 562 M | ||
|
Anixa Biosciences
ANIX
|
-0.0846 | $ 2.9 | 0.66 % | $ 94.1 K | ||
|
Fluidigm Corporation
FLDM
|
-13.6 | - | 1.08 % | $ 308 M | ||
|
Biodesix
BDSX
|
-8.27 | $ 26.63 | 1.72 % | $ 201 M | ||
|
Biomerica
BMRA
|
-1.7 | $ 2.34 | 1.3 % | $ 6.82 M | ||
|
BioNano Genomics
BNGO
|
-1.43 | $ 1.2 | 1.25 % | $ 6.53 M | ||
|
Burning Rock Biotech Limited
BNR
|
5.84 | $ 10.71 | 11.22 % | $ 113 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
20.8 | - | - | $ 10.7 B | ||
|
Agilent Technologies
A
|
20.2 | $ 146.85 | 0.59 % | $ 41.7 B | ||
|
Centogene N.V.
CNTG
|
0.283 | - | -6.23 % | $ 30.6 M | ||
|
Global Cord Blood Corporation
CO
|
-4.15 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
-2.67 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-0.932 | - | 0.12 % | $ 80.1 M | ||
|
Bioventus
BVS
|
10 | $ 13.83 | 0.42 % | $ 921 M | ||
|
CareDx, Inc
CDNA
|
-65.8 | $ 50.31 | 2.05 % | $ 2.68 B | ||
|
Celcuity
CELC
|
-32.4 | $ 93.02 | 0.75 % | $ 4.35 B | ||
|
Co-Diagnostics
CODX
|
0.0391 | $ 1.12 | 2.55 % | $ 1.49 M | ||
|
Charles River Laboratories International
CRL
|
26.6 | $ 280.76 | 0.54 % | $ 13.9 B | ||
|
Castle Biosciences
CSTL
|
-227 | $ 32.76 | 1.03 % | $ 950 M | ||
|
Danaher Corporation
DHR
|
20.1 | $ 205.23 | 0.53 % | $ 146 B | ||
|
DarioHealth Corp.
DRIO
|
-0.303 | $ 7.03 | 3.72 % | $ 28 M | ||
|
DexCom
DXCM
|
24.2 | $ 84.53 | 0.02 % | $ 33 B | ||
|
Fulgent Genetics
FLGT
|
-8.71 | $ 20.2 | 2.38 % | $ 622 M |